
|Videos|July 21, 2023
Impact of Personalized Dosing of Faricimab on Treatment Outcomes in nAMD
Author(s)Varun Chaudhary, MD, FRCS(C)
Dr Varun Chaudhary discusses the impact of personalized treat-and-extend-based dosing on visual and anatomic outcomes of faricimab in the TENAYA and LUCERNE clinical trials in neovascular AMD.
Advertisement
Episodes in this series
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
European Dry Eye Society Congress 2026: real-world evidence on Artelac Complete in dry eye disease
2
Demodex blepharitis: Closing the diagnostic gap to improve ocular surface health
3
Q&A: Uveitis risk rises as immune checkpoint inhibitor use expands
4
AI-predicted retinal function shows promise in geographic atrophy
5


























